Takahiro Fukuda Selected Research

Bone Marrow Transplantation (Transplantation, Bone Marrow)

1/2022	Decision Analysis for Unrelated Bone Marrow Transplantation or Immediate Cord Blood Transplantation for Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Complete Remission.
1/2021	Donor UNC-93 Homolog B1 genetic polymorphism predicts survival outcomes after unrelated bone marrow transplantation.
11/2020	Updated Comparison of 7/8 HLA Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Umbilical Cord Blood Transplantation as Alternative Donors in Adults with Acute Leukemia.
3/2020	A decision analysis comparing unrelated bone marrow transplantation and cord blood transplantation in patients with aggressive adult T-cell leukemia-lymphoma.
2/2020	Donor Heme Oxygenase-1 Promoter Gene Polymorphism Predicts Survival after Unrelated Bone Marrow Transplantation for High-Risk Patients.
12/2019	High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantation.
1/2019	Recipient ADAMTS13 Single-Nucleotide Polymorphism Predicts Relapse after Unrelated Bone Marrow Transplantation for Hematologic Malignancy.
1/2019	Comparison of HLA Allele Mismatch and Antigen Mismatch in Unrelated Bone Marrow Transplantation in Patients with Leukemia.
7/2017	Toll-like receptor genetic variations in bone marrow transplantation.
6/2017	Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takahiro Fukuda Research Topics

Disease

70	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2022 - 01/2005
52	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2022 - 10/2003
38	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2022 - 02/2009
34	Leukemia 01/2022 - 10/2003
33	Neoplasms (Cancer) 01/2022 - 05/2007
30	Hematologic Neoplasms (Hematological Malignancy) 08/2022 - 08/2007
24	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2022 - 12/2004
20	Infections 10/2022 - 08/2003
18	Philadelphia Chromosome 09/2022 - 11/2010
18	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 04/2022 - 08/2012
16	Lymphoma (Lymphomas) 01/2021 - 04/2005
14	Bronchiolitis Obliterans Syndrome 01/2022 - 12/2006
9	Disease Progression 12/2021 - 07/2013
7	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2022 - 03/2012
7	Residual Neoplasm 01/2022 - 01/2018
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2021 - 08/2012
6	Parkinson Disease (Parkinson's Disease) 01/2022 - 11/2006
6	Encephalitis (Encephalitis, Rasmussen) 01/2020 - 11/2006
5	Aplastic Anemia (Anemia, Hypoplastic) 01/2021 - 04/2013
4	Hodgkin Disease (Hodgkin's Disease) 09/2022 - 02/2015
4	Multiple Myeloma 01/2022 - 01/2016
4	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022 - 01/2017
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2021 - 08/2012
4	Pathologic Complete Response 11/2021 - 08/2012
4	Neoplasm Metastasis (Metastasis) 08/2021 - 05/2007
4	Virus Diseases (Viral Diseases) 12/2020 - 10/2011
4	Chromosome Aberrations (Chromosome Abnormalities) 01/2020 - 10/2018
4	Mucopolysaccharidosis II (Hunter Syndrome) 01/2020 - 09/2012
4	Esophageal Squamous Cell Carcinoma 01/2020 - 09/2012
3	Body Weight (Weight, Body) 01/2022 - 10/2006
3	Aspergillosis 12/2021 - 07/2004
3	B-Cell Lymphoma (Lymphoma, B Cell) 04/2020 - 08/2018
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 09/2012
3	Carcinoma (Carcinomatosis) 01/2020 - 01/2012
3	Pneumonia (Pneumonitis) 01/2020 - 10/2003
3	Primary Myelofibrosis (Myelosclerosis) 01/2020 - 01/2019
3	Communicable Diseases (Infectious Diseases) 12/2019 - 11/2006
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 07/2006
3	Neutropenia 09/2010 - 11/2006
2	COVID-19 10/2022 - 01/2021
2	Gastroenteritis 01/2022 - 07/2015
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 02/2019
2	Thymoma (Thymic Carcinoma) 10/2021 - 08/2005
2	Breast Neoplasms (Breast Cancer) 10/2021 - 08/2018
2	Febrile Neutropenia 11/2020 - 10/2020
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 08/2020 - 04/2020

Drug/Important Bio-Agent (IBA)

12	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2022 - 02/2005
11	Busulfan (Busulfex)FDA Link 01/2022 - 01/2005
8	fludarabineIBA 01/2022 - 09/2013
8	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2022 - 12/2016
7	HLA Antigens (Human Leukocyte Antigens)IBA 09/2022 - 02/2009
6	Tyrosine Kinase InhibitorsIBA 08/2022 - 09/2017
6	SteroidsIBA 01/2022 - 07/2015
6	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2022 - 09/2014
6	AntigensIBA 01/2022 - 03/2016
6	Tacrolimus (Prograf)FDA LinkGeneric 12/2021 - 04/2005
6	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 12/2017
6	Pharmaceutical PreparationsIBA 12/2020 - 01/2012
5	Etoposide (VP 16)FDA LinkGeneric 07/2022 - 11/2011
5	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 09/2013
5	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020 - 08/2003
5	GlycosaminoglycansIBA 01/2020 - 09/2012
4	Methotrexate (Mexate)FDA LinkGeneric 12/2021 - 03/2016
4	Antiviral Agents (Antivirals)IBA 01/2021 - 04/2015
4	Rituximab (Mabthera)FDA Link 04/2020 - 06/2004
4	ThrombomodulinIBA 01/2020 - 10/2015
4	CytokinesIBA 12/2019 - 05/2008
4	HLA-A Antigens (HLA-A)IBA 01/2019 - 03/2012
4	EnzymesIBA 02/2014 - 05/2010
4	Proteins (Proteins, Gene)FDA Link 11/2008 - 10/2006
3	Monoclonal AntibodiesIBA 09/2022 - 10/2016
3	Calcineurin InhibitorsIBA 01/2022 - 06/2021
3	Core Binding Factors (Core-Binding Factor)IBA 11/2021 - 10/2013
3	Foscarnet FDA LinkGeneric 12/2020 - 09/2010
3	Cisplatin (Platino)FDA LinkGeneric 11/2020 - 07/2004
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2017 - 04/2005
3	Ganciclovir (Cytovene)FDA LinkGeneric 12/2015 - 09/2010
2	CCAAT-Enhancer-Binding Protein-alphaIBA 11/2022 - 01/2016
2	Biological ProductsIBA 07/2022 - 01/2018
2	letermovirIBA 01/2022 - 06/2021
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022 - 12/2021
2	KIR ReceptorsIBA 12/2021 - 01/2018
2	GlucocorticoidsIBA 11/2021 - 01/2016
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2021 - 11/2019
2	SynucleinsIBA 01/2021 - 12/2018
2	DEET (DET)IBA 11/2020 - 10/2020

Therapy/Procedure

122	Hematopoietic Stem Cell Transplantation 10/2022 - 08/2003
90	Cell Transplantation 09/2022 - 11/2006
65	Transplantation 10/2022 - 12/2004
39	Stem Cell Transplantation 09/2022 - 08/2005
39	Drug Therapy (Chemotherapy) 04/2022 - 07/2004
35	Therapeutics 10/2022 - 08/2003
34	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022 - 12/2004
14	Homologous Transplantation 11/2021 - 01/2016
12	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 10/2022 - 09/2012
5	Induction Chemotherapy 11/2020 - 11/2010
4	Enzyme Replacement Therapy 01/2018 - 09/2012
3	Autologous Transplantation 01/2021 - 12/2016
2	Radiotherapy 08/2021 - 05/2007
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2021 - 12/2004